logo

RKDA

Arcadia Biosciences·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

RKDA fundamentals

Arcadia Biosciences (RKDA) released its earnings on Nov 7, 2025: revenue was 1.30M (YoY -15.29%), missed estimates; EPS was 0.63 (YoY +153.39%), beat estimates.
Revenue / YoY
1.30M
-15.29%
EPS / YoY
0.63
+153.39%
Report date
Nov 7, 2025
EPS
Revenue

Revenue & Expenses

RKDA has released its 2025 Q3 earnings report, with revenue of 1.30M, reflecting a YoY change of -15.29%, and net profit of 856.00K, showing a YoY change of 153.10%. The Sankey diagram below clearly presents RKDA's revenue sources and cost distribution.

Key Indicators

Arcadia Biosciences (RKDA) key financial stats and ratios, covering profitability, financial health, and leverage.
Arcadia Biosciences (RKDA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Arcadia Biosciences (RKDA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Arcadia Biosciences (RKDA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Arcadia Biosciences (RKDA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Arcadia Biosciences (RKDA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield